HCPLive Network

ACG 2011: Challenging Issues in Ulcerative Colitis Therapy - Adherence and Quality of Life [Podcast]

Raymond Cross, MD, associate professor of medicine and director of the inflammatory bowel disease program at the University of Maryland School of Medicine, describes challenges with adherence to therapy and discusses methods to improve quality of life.




Further Reading
Analysis of a dozen phase III trials indicates that patients with atrial fibrillation face significantly less risk of major, fatal, and intracranial bleeding if they take target-specific oral anticoagulants rather than vitamin K antagonists.
Calculation and interpretation of the anion gap is extremely useful in the evaluation and treatment of the patient with metabolic acidosis. In this installment, we look at case examples involving patients with multiple sclerosis and urosepsis; COPD, diabetes, and renal failure; and type 1 diabetes.
The US Department of Homeland Security (DHS) will begin limiting the airports through which travelers from Ebola-stricken countries may enter the US. Starting tomorrow, all these passengers will be forced to fly through 5 US airports: JFK International in New York, Newark Liberty International in Newark, NJ, Washington Dulles International in Dulles, VA, Hartsfield-Jackson International in Atlanta, GA, and Chicago O’Hare International in Chicago, Ill.
High-dose supplementation with resveratrol improves bone mineral density in obese men with metabolic syndrome, according to a study published online Oct. 16 in the Journal of Clinical Endocrinology & Metabolism.
Unplanned hospitalizations among elderly patients with gastrointestinal cancer are common, according to research published online Oct. 6 in the Journal of Clinical Oncology.
High-intensity statin therapy can alter the progressive nature of diabetic atherosclerosis, according to a study published online Sept. 4 in Diabetes Care.
A new implantable eye device might make reading glasses a thing of the past, according to research presented at the annual meeting of the American Academy of Ophthalmology, held from Oct. 18 to 21 in Chicago.
More Reading
Analysis of a dozen phase III trials indicates that patients with atrial fibrillation face significantly less risk of major, fatal, and intracranial bleeding if they take target-specific oral anticoagulants rather than vitamin K antagonists.